Counteraction by stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design
A 2024 meta-analysis in JCEM, Inositol for Polycystic Ovary Syndrome: Systematic Review and Meta-analysis , found selective metabolic benefits in some contexts, which does not validate MIC injections for universal weight loss
Power up with BPC-157 from APH Science, blending 500 mcg BPC-157, 25 mg zinc, and 4.5 mg magnesium stearate for rapid healing and resilience.
Compound stability characteristics
It has also demonstrated the potential to reduce inflammation, improve gut health, and even accelerate recovery from surgery or injury
IBD is a chronic condition that causes inflammation of the digestive tract